Q2 FY2027 · ended Jul 31, 2026 · Revenue $437,514, -29.7% YoY · Filed Sep 4, 2026
Nutriband Inc. (NTRB) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q2 of fiscal 2027, the quarter ended Jul 31, 2026, it reported revenue of $437,514 and a net loss of $880,561. As of Jul 31, 2026 it held $3.4 million in cash and investments and $66,178 in total debt.
Revenue
$437,514
-29.7% vs year-ago quarter
Net income
$-880,561
+56.0% vs year-ago quarter
Operating cash flow
$-584,999
+55.5% vs year-ago quarter
Free cash flow
$-731,830
+40.9% vs year-ago quarter
EPS
$-0.07
+96.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
12.16M
+1.0% vs year-ago quarter
Net cash
$3.36M
Q2 FY2027
Operating margin
-435.6%
TTM
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- NTRB (Nasdaq)
- Fiscal year ends
- January 31
- Incorporated in
- NV
- Headquarters
- Orlando, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1676047
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2027 Jul 31, 2026 |
Q1 FY2027 Apr 30, 2026 |
Q4 FY2026 Jan 31, 2026 |
Q3 FY2026 Oct 31, 2025 |
Q2 FY2026 Jul 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $437,514 | $433,399 | $400,709 | $346,058 | $622,452 |
| Operating income | -$890,637 | -$1.3M | -$1.0M | -$3.9M | -$2.0M |
| Net income | -$880,561 | -$1.2M | -$968,059 | -$3.9M | -$2.0M |
| Diluted EPS | -$0.07 | -$0.10 | -$0.08 | -$0.32 | -$2.12 |
| Operating cash flow | -$584,999 | -$563,104 | -$731,830 | -$1.8M | -$1.3M |
| Free cash flow | — | — | -$731,830 | -$1.8M | -$1.3M |
| Total assets | $6.3M | $6.9M | $7.5M | $8.4M | $10.2M |
| Total liabilities | $964,358 | $902,312 | $868,447 | $870,208 | $1.7M |
| Stockholders' equity | $5.3M | $6.0M | $6.7M | $7.5M | $8.5M |
| Cash and investments | $3.4M | $4.0M | $4.6M | $5.3M | $7.0M |
| Total debt | $66,178 | $73,551 | $80,758 | $87,803 | $94,689 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2026 | Sep 21, 2026 |
| 10-Q | Quarterly report | Sep 4, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 22, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | Jun 11, 2026 | Apr 30, 2026 |
| 10-K/A | Amended annual report | May 18, 2026 | Jan 31, 2026 |
| 10-K | Annual report | Apr 29, 2026 | Jan 31, 2026 |
All 261 Nutriband Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.